Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema

Status Not yet recruiting

Clinical Trial Summary

Most patients undergoing cataract surgery suffer from corneal edema after the surgery.

Brimonidine drops are a well known and safe Anti-glaucoma medication. the investigators have made several clinical observations that patients receiving Brimonidine drops had a faster resolution of their corneal edema even if they had normal intra-ocular pressure.

The investigators believe that administering topical Brimonidine to patients with significant post operative corneal edema will hasten the resolution of their corneal edema.

Clinical Trial Description

Most patients undergoing cataract surgery suffer from corneal edema after the surgery which temporarily reduces their visual acuity until corneal edema resolves over several weeks Brimonidine drops are a well known and safe Anti-glaucoma medication, used to lower intra ocular pressure.

there have been several clinical observations that patients receiving Brimonidine drops had a faster resolution of their corneal edema even in the presence of normal intra-ocular pressure.

The investigators postulated that administering topical Brimonidine to patients with significant post operative corneal edema will hasten their recovery and visual improvement.

In order to prove that Brimonidine drops contribute to faster resolution of cornel edema and visual improvement, the study will randomly compare 50 post cataract surgery patients (group A)who will be administered Brimonidine to 2 control groups (50 people in each group):

group B will be given topical timolol drops 0.5% (another well recognized anti glaucoma medication which reduces intra-ocular pressure by different mechanism than Brimonidine.

Group C will not be given any test drug. All 3 groups will receive the regular post operative medications which include corticosteroids and antibiotics. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00800423
Study type	Interventional
Source	Rabin Medical Center
Contact	Anat Robinson, MD
Phone	9729377176
Email	robina@clalit.org.il
Status	Not yet recruiting
Phase	Phase 3
Start date	January 2009
Completion date	January 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06019806` - Effects of Forward Head Posture Correction on Visual Acuity in Low Level Visually Impaired University Students	N/A
Completed	`NCT04567186` - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Hyperopic Population	N/A
Completed	`NCT02568254` - Evaluation of Three Daily Disposable Contact Lenses	N/A
Completed	`NCT01951703` - Senofilcon A Investigational Manufacturing Process	N/A
Terminated	`NCT00637468` - EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye	Phase 3
Recruiting	`NCT04632901` - A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
Active, not recruiting	`NCT03747601` - Temporal Interference Brain Stimulation	N/A
Completed	`NCT06131476` - Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop	Phase 1
Recruiting	`NCT05414565` - Post-Market Study of Alcon Intraocular Lenses
Completed	`NCT05056870` - Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats	N/A
Completed	`NCT04615507` - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2	N/A
Completed	`NCT05099380` - Validation of Senofilcon A With New UV / HEV Filter	N/A
Completed	`NCT03713281` - Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population
Completed	`NCT05582304` - Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study	N/A
Completed	`NCT03742271` - Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population	N/A
Completed	`NCT04995055` - Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function	N/A
Completed	`NCT05554640` - Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses	N/A
Completed	`NCT01926704` - MTF Image Modifications	N/A
Completed	`NCT04649606` - Dynamic Characterisation of Meibomian Gland Structure
Completed	`NCT05101252` - Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.